Duopharma makes RM15.4mil net profit in Q2


KUALA LUMPUR (Bernama) -- Duopharma Biotech Bhd’s net profit for the second quarter ended June 30, 2021 increased to RM15.39 million from RM14.73 million recorded in the same period last year.

Revenue rose to RM155.44 million from RM143.33 million previously, the group said in a filing with Bursa Malaysia today.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Duopharma Biotech

   

Next In Business News

Ringgit retreats vs US$ ahead of personal consumption expenditure reading
Oil prices rise as US official eases market concerns over economic headwinds
Inflation in Japan's capital slows more than expected, slides below BOJ goal
FBM KLCI opens lower as investors book profits
Trading ideas: Al-'Aqar REIT, Pantech, AirAsia X, Inta Bina, Khee San, Infoline, Heineken, Agricore
Capital A to dispose of 100% stake in AirAsia Aviation Group, AirAsia for RM6.8bil
Meta projects higher spending, weaker revenue
Property market recovery on the horizon
Buyout proposal for Anglo American could reshape copper market
A test bed for airline subscription model

Others Also Read